Chief Executive OfficerMr. Yonkin has more than 25 years of business experience in the clinical diagnostics field, coming from previous positions as Vice President for Strategic Projects at Alere, Inc. and President of Alere's predecessor Inverness Medical Innovations. Mr. Yonkin was formerly President of Nutritionals and Pharmaceuticals and Vice President of U.S. Sales and Marketing at Inverness. His previous experience includes management positions in sales, marketing and product development at Baxter, Genzyme and Inverness. Mr. Yonkin is a graduate of Lock Haven University.
Andrew E. Levin, Ph.D.
President and Scientific Director
Dr. Levin is the founder of the company and developed its first patented products. He has over 20 years of research experience focused on infectious disease assay techniques and a large portfolio of patents and intellectual property. He has overseen the development and production of over 20 in vitro diagnostic products and 10 instruments. He organized and directed clinical trials and FDA submissions for five products which resulted in FDA approvals. Dr. Levin has been awarded over eighteen SBIR grants and contracts from the NIH and CDC. Prior to founding Immunetics, he was the recipient of an NIH postdoctoral fellowship at Harvard University. Dr. Levin received his undergraduate degree in Biochemistry from Princeton University and Ph.D. in Molecular Biology from The University of Wisconsin.
Joan Clifford, MT (ASCP), MPH
Director, Clinical Affairs
Prior to joining Immunetics, Ms. Clifford was Director of Clinical Research at Candela Corporation overseeing all activities related to clinical research studies. She has over 20 years of experience in clinical affairs management, including regulatory affairs and quality assurance. Her experience includes medical device, pharmaceutical, and academic arenas in the therapeutic areas of diabetes, anesthesiology, oncology and dermatology. Ms. Clifford received her BS in Medical Technology from Northeastern University and her Masters in Public Health from the University of Massachusetts.
Richard Pinkowitz, Ph.D.
Dr. Pinkowitz has held senior management positions in sales and marketing at major healthcare companies, most recently including Inverness Medical Technology and its predecessor, Selfcare. He brings over 30 years of experience in sales of healthcare products and services, and was on the management team which brought Inverness from start-up to $50 million in sales.
Houry Youssoufian, M.B.A., C.P.A.
Vice President of Finance
Ms. Youssoufian has over 20 years of experience in financial management in the life sciences industry. She has held senior level finance, accounting and administrative positions in small and large publicly traded life sciences companies, most recently as Site Head of Finance at Novartis Institutes of Biomedical Research and previously at Biotransplant Inc. and Flagship Ventures. She received her Bachelor of Science in Biology from the University of Massachusetts and her M.B.A from Simmons Graduate School of Management.
Lynda S. Mungo, Ph.D.
Dr. Mungo oversees the Quality Assurance and Quality Control Department at Immunetics. Before joining Immunetics, Dr. Mungo was a Senior Manager in the Quality Control Department at MBL, an FDA-licensed manufacturer of vaccines and other biologic therapeutics. Dr. Mungo received her undergraduate degree in Biology from Colby College and Ph.D. in Biology from Dartmouth College. She also conducted postdoctoral research in biochemistry and molecular biology at Brown University and Boston University Medical School.